As of Apr 28
| -0.10 / -1.25%|
The 1 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +76.54% increase from the last price of 7.93.
The current consensus among 5 polled investment analysts is to Hold stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.